A Unique Roadblock for Pfizer’s Osteoarthritis Drug
We’ve heard of drugs underperforming in clinical trials, but is it possible for a drug to over-perform?
969
FDA, Clinical Trial News: $ABIO, $GENZ, $KV-A, $SLXP
Shares of ARCA Biopharma (NASDAQ:ABIO) are soaring today on news of an issued patent that includes the methods of treating heart failure patients with Gencaro (bucindolol) based on genetic testing.
Protalix Granted Fast-Track Review for Gaucher Drug
The U.S. Food and Drug Administration has granted a fast-track review to Protalix BioTherapeutics’ experimental treatment for Gaucher disease.